![]() |
市場調查報告書
商品編碼
1909183
彈性成像診斷市場規模、佔有率及成長分析(按技術、應用、最終用戶和地區分類)-2026-2033年產業預測Elastography Imaging Market Size, Share, and Growth Analysis, By Technology (Ultrasound Elastography, Magnetic Resonance Elastography ), By Application (General Imaging / Radiology, Hepatology ), By End-User, By Region - Industry Forecast 2026-2033 |
||||||
全球彈性成像市場規模預計在 2024 年達到 29.1 億美元,從 2025 年的 31.4 億美元成長到 2033 年的 57.2 億美元,在預測期(2026-2033 年)內複合年成長率為 7.8%。
由於對非侵入性診斷方案的需求不斷成長、慢性肝病和乳癌發病率上升,以及超音波和磁振造影彈性成像技術的創新,全球彈性成像市場正經歷顯著成長。意識提升,以及政府的支持性政策,預計將進一步加速市場擴張。此外,新興市場對彈性成像服務的快速接受度以及攜帶式成像技術的進步也推動了這一成長趨勢。主要企業正在加大研發投入,以提高影像診斷的準確性並拓展其在臨床環境中的應用。這些因素共同推動彈性成像市場持續成長,並擴大其在整體診斷成像技術領域的作用。
推動全球彈性成像市場發展的因素
代謝相關性脂肪肝的日益普遍促使肝臟硬度測量成為常規檢查手段,因為2D剪切波彈性成像在特定閾值下展現出較高的準確性。透過將超音波引導衰減參數與剪切波資料結合,醫護人員可以根據患者發生危及生命事件的風險對其進行有效分層。此外,乳房彈性成像已成為緻密型乳房篩檢的有效工具,能夠以高靈敏度和特異性識別惡性微鈣化灶。彈性成像在腫瘤學領域的應用日益廣泛,提高了其在放射科的利用率,並鞏固了其作為傳統切片檢查的非侵入性替代方案的地位。
限制全球彈性成像診斷市場發展的因素
全球彈性成像市場面臨阻礙其擴張的許多挑戰。保險公司施加的限制,例如某些慢性肝病中僅針對晚期肝纖維化的承保代碼,阻礙了彈性成像在篩檢的廣泛應用。此外,一些保險公司將非肝臟應用的彈性成像歸類為研究性項目,導致心臟病學和肌肉骨骼成像等領域的報銷延遲。事先核准要求增加了行政延誤,進一步阻礙了這些成像方式的常規應用。此外,心臟彈性成像缺乏標準化的支付模式,阻礙了指南建議的實施,而擴大承保範圍則取決於大規模研究能否證明其成本效益。
全球彈性成像診斷市場趨勢
全球彈性成像市場正呈現出顯著的趨勢,即加速整合人工智慧 (AI) 解決方案,以提高診斷準確性和營運效率。 AI 驅動的演算法能夠簡化組織硬度分析,最大限度地減少醫生間解讀差異,並促進與臨床基準相符的預測分析,尤其是在肝纖維化等領域。主要企業正在迅速推出配備 AI 功能的先進彈性成像系統,實現即時決策,從而加快檢查流程並提高疾病早期檢出率,尤其是在乳癌和非酒精性脂肪肝方面。 AI 技術與彈性成像的融合有望重新定義醫學影像診斷的最佳實踐,並改善患者的治療效果。
Global Elastography Imaging Market size was valued at USD 2.91 Billion in 2024 and is poised to grow from USD 3.14 Billion in 2025 to USD 5.72 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
The global elastography imaging market is experiencing significant growth driven by the rising demand for non-invasive diagnostic options, increasing prevalence of chronic liver diseases and breast cancer, and innovations in ultrasound and MRI elastography techniques. Heightened awareness among the public for early disease detection, alongside supportive government initiatives, is expected to further accelerate market expansion. Additionally, the rapid adoption of elastography services in emerging markets and advancements in portable imaging technologies are contributing to this upward trend. Key industry players are investing in research and development to improve imaging accuracy and increase its application in clinical settings. Collectively, these factors are poised to enhance the elastography market and broaden its role in diagnostic imaging as a whole.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastography Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Elastography Imaging Market Segments Analysis
Global Elastography Imaging Market is segmented by Technology, Application, End-User and region. Based on Technology, the market is segmented into Ultrasound Elastography and Magnetic Resonance Elastography (MRE). Based on Application, the market is segmented into General Imaging / Radiology, Hepatology (Liver / Fibrosis), Breast Imaging, Cardiology, Orthopedic & Musculoskeletal and Urology / Vascular / Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Imaging Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Elastography Imaging Market
The rising prevalence of metabolic dysfunction-associated steatotic liver disease is encouraging the routine adoption of liver stiffness measurements, as two-dimensional shear-wave elastography delivers impressive accuracy at specific cutoffs. By integrating ultrasound-guided attenuation parameters with shear-wave data, healthcare providers can effectively stratify patients based on their risk of life-threatening events. Additionally, breast elastography has emerged as a valuable tool in dense breast screening, enabling the identification of malignant microcalcifications with high sensitivity and specificity. The increasing utilization of elastography in oncology enhances equipment use in radiology suites, reinforcing its position as a preferred non-invasive alternative to traditional biopsies.
Restraints in the Global Elastography Imaging Market
The Global Elastography Imaging market faces significant challenges that hinder its expansion. Restrictions from insurance providers, such as limiting coverage for specific codes to advanced hepatic fibrosis in select chronic liver conditions, restrict broader application for screening. Moreover, some insurers classify elastography as investigational for non-liver uses, which slows down reimbursement in fields like cardiology and musculoskeletal imaging. The need for prior-authorization introduces additional administrative delays, further discouraging routine utilization of these imaging modalities. Additionally, the lack of standardized payment models for cardiac elastography creates obstacles for guideline recommendations, with coverage advancements reliant on large-scale studies that showcase cost-effectiveness.
Market Trends of the Global Elastography Imaging Market
The Global Elastography Imaging market is witnessing a significant trend towards the accelerated integration of artificial intelligence (AI) solutions, enhancing diagnostic precision and operational efficiency. AI-driven algorithms are streamlining the analysis of tissue stiffness, minimizing variability in interpretation across practitioners, and facilitating predictive analytics aligned with clinical benchmarks, particularly in areas like liver fibrosis. Major industry players are launching advanced elastography systems equipped with AI capabilities, enabling real-time decision-making that expedites examination processes and bolsters early disease detection, notably in breast cancer and non-alcoholic fatty liver disease. This convergence of AI technology and elastography is set to redefine best practices and improve patient outcomes in medical imaging.